Back

ChemBERTaPolyPharm: Modeling polypharmacy side effects with ChemBERTa and PubMed Encoders

Gromova, A. A.; Maida, A. S.

2025-05-25 bioinformatics
10.1101/2025.05.20.655109 bioRxiv
Show abstract

Polypharmacy side effects occur when drug combinations trigger unexpected interactions, altering therapeutic outcomes. During which the activity of one drug may change favorably or unfavorably if taken with the other drug. Drug interactions are rare and are only observed in clinical studies. Thus, the discovery and detection of polypharmacy side effects remains a challenge. Our approach achieves an impressive average F1 score of 0.93, demonstrating its efficacy in capturing drug interaction patterns. 1 Submission of papers to NeurIPS 2025Please read the instructions below carefully and follow them faithfully.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.